Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00206 |
| Species: | Homo sapiens |
| Position : | chr12:47732000-47733500 |
| Year: | 2017 |
| Title: | AML1/ETO trans-activates c-KIT expression through the long range interaction between promoter and intronic enhancer |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | cervical cancer |
| PMID: | 29236325 |
| MONDO: | MONDO:0001156 |
| Tissue: | Cervical Epithelium |
| Tissue Ontology ID: | UBERON:0000002 |
| Cell Source: | HeLa |
| CVCL ID: | CVCL_0030 |
| Cell Type: | cervical adenocarcinoma cell |
| Cell Ontology ID: | CL:0000069 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay |
| High Throughput Method: | ChIP-seq, ATAC-seq, RNA-seq |
| Low Throughput Method: | Luciferase Reporter Assay, CRISPR Knockout, RT-RT-qPCR |
| Target gene : | AMIGO2 |
| TF name : | BRD4 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|